Cambridge Cognition Holdings PLC (LON:COG)‘s stock had its “corporate” rating restated by FinnCap in a research report issued to clients and investors on Thursday.

Shares of Cambridge Cognition Holdings PLC (LON:COG) opened at 78.00 on Thursday. The firm’s 50-day moving average price is GBX 70.67 and its 200-day moving average price is GBX 47.40. Cambridge Cognition Holdings PLC has a 12-month low of GBX 30.00 and a 12-month high of GBX 103.00. The company’s market capitalization is GBX 14.54 million.

Cambridge Cognition Holdings PLC Company Profile

Cambridge Cognition Holdings plc is a holding company. The Company operates through its wholly owned subsidiary, Cambridge Cognition Limited (CCL). It develops and commercializes computerized neuropsychological tests for sale, principally in the United Kingdom, the United States and Europe. The Company has three segments: Healthcare, which includes medical software for use in healthcare delivery settings; Academic Research, which includes cognitive test products for researchers working in a non-regulated environment, and Clinical Trials, which includes products and services for use in regulated pharmaceutical clinical trials.

Receive News & Stock Ratings for Cambridge Cognition Holdings PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition Holdings PLC and related stocks with our FREE daily email newsletter.